Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.

Publication ,  Journal Article
Sawinski, D; Forde, KA; Wyatt, CM
Published in: Am J Kidney Dis
July 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Kidney Dis

DOI

EISSN

1523-6838

Publication Date

July 2018

Volume

72

Issue

1

Start / End Page

7 / 9

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Sulfonamides
  • Quinoxalines
  • Pyrrolidines
  • Proline
  • Leucine
  • Lactams, Macrocyclic
  • Kidney Failure, Chronic
  • Humans
  • Hepatitis C
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sawinski, D., Forde, K. A., & Wyatt, C. M. (2018). New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat. Am J Kidney Dis, 72(1), 7–9. https://doi.org/10.1053/j.ajkd.2018.01.049
Sawinski, Deirdre, Kimberly A. Forde, and Christina M. Wyatt. “New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.Am J Kidney Dis 72, no. 1 (July 2018): 7–9. https://doi.org/10.1053/j.ajkd.2018.01.049.
Sawinski, Deirdre, et al. “New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.Am J Kidney Dis, vol. 72, no. 1, July 2018, pp. 7–9. Pubmed, doi:10.1053/j.ajkd.2018.01.049.
Journal cover image

Published In

Am J Kidney Dis

DOI

EISSN

1523-6838

Publication Date

July 2018

Volume

72

Issue

1

Start / End Page

7 / 9

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Sulfonamides
  • Quinoxalines
  • Pyrrolidines
  • Proline
  • Leucine
  • Lactams, Macrocyclic
  • Kidney Failure, Chronic
  • Humans
  • Hepatitis C